Cancer therapy finds a solid target.
Secko
David
D
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis; D001943:Breast Neoplasms / Q000473:pathology; D004268:DNA-Binding Proteins / Q000187:drug effects* / Q000502:physiology*; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy / Q000503:physiopathology; D051379:Mice; D009369:Neoplasms / Q000188:drug therapy* / Q000503:physiopathology / Q000662:veterinary; D016376:Oligonucleotides, Antisense / Q000627:therapeutic use*; D050796:STAT3 Transcription Factor; D015534:Trans-Activators / Q000187:drug effects* / Q000502:physiology*; D014407:Tumor Cells, Cultured
D000970:Antineoplastic Agents; D004268:DNA-Binding Proteins; D016376:Oligonucleotides, Antisense; D050796:STAT3 Transcription Factor; C494086:STAT3 protein, human; C494087:Stat3 protein, mouse; D015534:Trans-Activators